Herein are reported two unusual thoracic locations of Castleman’s disease of hyaline vascular type that were surgically removed.
Case 2– A 24-year-old man was admitted with the complaint of chest pain on the anterior right side for one year. The findings in the physical exam, his medical history and the laboratory values were unremarkable. A CT of the thorax obtained after determining a hilar mass in the chest X-ray (Fig. 1b), showed a massive lesion located on the anterior right chest wall (Fig. 1d). The transthoracic needle aspiration biopsy of the lesion was nondiagnostic. Thus, a surgical intervention was planned. A right thoracotomy was done and the lesion, which was located at the level of the right fourth and fifth ribs, corresponding to the course of the internal thoracic artery, was totally removed (Fig. 2b). The lesion was highly vascular, wellcircumscribed and capsulated. The histopathological examination of the surgical specimen also revealed a hyaline vascular type of Castleman’s disease.
Although the majority of the cases occur within the chest, along the tracheobronchial tree in the mediastinum or the lung hilus, it has also been reported in other places such as the neck, pelvis, and abdomen.[2-4,7] The disease may also, however rarely, be observed in other places than these, as in our cases above. In the literature, according to our best knowledge, there are few reports on chest wall involvement,[8] while the reports on intrafissural development[9] and intraparenchymal localization are extremely rare.[10]
The clinical manifestation of Castleman’s disease is highly dependent on the histopathology of the lesion. Castleman’s disease can occur at any age, even during the childhood, with a peak frequency during adulthood. There is no sex predilection or identifiable risk factors in the development of the disease.[2] The tumor is often diagnosed after the onset of nonspecific thoracic symptoms such as coughing, dyspnea, and chest pain caused by tracheobronchial compression, but it can also be incidentally diagnosed in asymptomatic cases. Although the multicentric form is always symptomatic, the localized form is usually asymptomatic. However, cases with localized forms may have some nonspecific complaints such as asthenia, fever and weight loss.[2,11] Our patients, who had the localized form, also had thoracic symptoms, dry cough, and chest pain at their admission.
The most commonly detected radiological appearance of the localized form, including the chest wall involvement, is a homogenous, well-margined mass with high vascularity.[6,8] Pleural effusion may be observed. Calcification may sometimes be determined in some cases and it may indicate chronic disease.[12]
The diagnosis of Castleman’s disease is ultimately made by histology, thereby requiring either the removal or a biopsy of the lesion for definitive diagnosis. However, preoperative aspiration biopsy may fail to achieve a positive diagnosis as was shown by previously reported cases[8] and our second case. In addition, a needle biopsy may not be feasible and it can even be dangerous because of the high vascularization of the tumor, which increases the risk of bleeding. Therefore, such cases may ultimately require surgical exploration.
In contrast to the multicentric form, in which the disease has a more aggressive course with a poorer prognosis and the management of the cases is still problematic, the localized forms are mostly suitable for surgery and have a better prognosis if they are fully resectable wherever they are located.
In conclusion, two unusual thoracic (chest wall and intraparenchymal) manifestations of localized Castleman’s disease, of which the latter is extremely rare, have been presented in our report. Although it is rare, Castleman’s disease should be considered in the presence of masses that correspond to any lymphatic chain in the differential diagnosis. Preoperative biopsy may be nondiagnostic and it may cause bleeding due to the high vascularization of the lesions. In such cases, surgery seems to be the best option for the confirmation of the diagnosis and the management of the disease.
1) Castleman B, Iverson L, Menendez VP. Localized mediastinal
lymphnode hyperplasia resembling thymoma. Cancer
1956;9:822-30.
2) Keller AR, Hochholzer L, Castleman B. Hyaline-vascular
and plasma-cell types of giant lymph node hyperplasia of the
mediastinum and other locations. Cancer 1972;29:670-83.
3) Gökçe M, Okur E, Baysungur V, Yılmaz A, Halezaroğlu S.
Castleman hastalığı: 3 olgu nedeniyle. Türkiye Klinikleri
Arch Lung 2006;7:72-4.
4) Can D, Demir E, Tanaç R, Gülen F, Yenigün A, Soydan S, et
al. Localized castleman disease associated with bronchiectasis.
Turkish Respiratory Journal 2005;6:46-9.
5) Barrie JR, English JC, Müller N. Castleman’s disease of the
lung: radiographic, high-resolution CT, and pathologic findings.
AJR Am J Roentgenol 1996;166:1055-6.
6) Frizzera G. Castleman’s disease and related disorders. Semin
Diagn Pathol 1988;5:346-64.
7) İnci E, Mamak A, Dereköylü L, Güvenç MG, Cansız H, Akı
H. Hyalen vasküler castleman hastalığı: olgu sunumu. Türk
Otolarengoloji Arşivi 2003;41:158-61.
8) Rena O, Casadio C, Maggi G. Castleman’s disease: unusual
intrathoracic localization. Eur J Cardiothorac Surg 2001;
19:519-21.
9) Caus T, Leude E, Thomas P, Garbe L, Giudicelli R, Fuentes
P. Castleman’s disease. An intrapulmonary isolated form with
fissural exteriorization. Presse Med 1992;21:934-6. [Abstract]
10) Spedini C, Lombardi C, Lanzani G, Di Fabio D, Chiodera PL.
Castleman’s disease presenting as an asymptomatic solitary
pulmonary nodule. Monaldi Arch Chest Dis 1995;50:363-5.